Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Sales (2016 - 2017)

Rocket Pharmaceuticals (RCKT) has disclosed Return on Sales for 2 consecutive years, with 17.51% as the latest value for Q3 2017.

  • Quarterly Return on Sales fell 369.0% to 17.51% in Q3 2017 from the year-ago period, while the trailing twelve-month figure was 17.51% through Sep 2017, changed N/A year-over-year, with the annual reading at 17.51% for FY2015, 865.0% up from the prior year.
  • Return on Sales hit 17.51% in Q3 2017 for Rocket Pharmaceuticals, down from 42.49% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 49.17% in Q1 2016 to a low of 17.51% in Q3 2017.